Nevada Administrative Code
Chapter 449 - Medical and Other Related Facilities
FACILITIES FOR TREATMENT OF IRREVERSIBLE RENAL DISEASE
Construction; Health and Safety
Section 449.5325 - Hepatitis B surface antigen: Screening of patients; additional serologic screening
Universal Citation: NV Admin Code 449.5325
Current through September 16, 2024
1. Each candidate for dialysis at a facility must, if practicable, be screened for the hepatitis B surface antigen before being admitted to the facility. The screening may be performed at any time within 30 days before the person is admitted to the facility.
2. Additional serologic screening must be based on the antigen or antibody status of the patient, as follows:
(a) If the patient tests negative
for the hepatitis B surface antigen, the facility shall screen the patient at
least once each month.
(b) If the
patient tests positive for the hepatitis B surface antigen or anti-hepatitis B
surface antigen, the facility may screen the patient less than once each month
if the policy of the facility concerning the screening of that patient complies
with the provisions of Appendices I and II of the National Surveillance
of Dialysis-Associated Diseases in the United States, adopted by
reference pursuant to the provisions of NAC 449.5315.
Added to NAC by Bd. of Health by R130-99, eff. 8-1-2001
NRS 449.0302
Disclaimer: These regulations may not be the most recent version. Nevada may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
